Stockscreener 앱 받기
11.54
5.02%
-0.61
시간 외 거래:
11.61
0.07
+0.61%
전일 마감가:
$12.15
열려 있는:
$11.98
하루 거래량:
3.19M
Relative Volume:
0.81
시가총액:
$1.28B
수익:
$631.73M
순이익/손실:
$-239.78M
주가수익비율:
-5.7129
EPS:
-2.02
순현금흐름:
$-33.45M
1주 성능:
-7.46%
1개월 성능:
+6.75%
6개월 성능:
-28.59%
1년 성능:
-30.90%
1일 변동 폭
$11.45
$12.06
1주일 범위
$11.45
$12.77
52주 변동 폭
$6.78
$24.76
10X 제노믹스 Stock (TXG) Company Profile
명칭
10 X Genomics Inc
전화
(925) 401-7300
주소
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
TXG을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
11.54 | 1.54B | 631.73M | -239.78M | -33.45M | -2.02 |
|
VEEV
Veeva Systems Inc
|
281.00 | 46.13B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
58.01 | 10.01B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
97.08 | 8.42B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
60.25 | 11.54B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
36.97 | 6.64B | 906.14M | -52.62M | 89.62M | -0.3621 |
10X 제노믹스 Stock (TXG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-13 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-09-03 | 개시 | Leerink Partners | Outperform |
| 2024-07-22 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-07-18 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-10 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2024-06-27 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-05-01 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-12-12 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-05-10 | 개시 | Barclays | Overweight |
| 2023-03-31 | 개시 | Stephens | Overweight |
| 2023-02-02 | 개시 | UBS | Neutral |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-08-18 | 다운그레이드 | Goldman | Neutral → Sell |
| 2022-07-25 | 개시 | Canaccord Genuity | Buy |
| 2022-07-15 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-07-15 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-09-14 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-03-15 | 개시 | William Blair | Outperform |
| 2020-12-02 | 개시 | Goldman | Neutral |
| 2020-09-09 | 개시 | Morgan Stanley | Overweight |
| 2020-07-10 | 개시 | Stifel | Buy |
| 2020-03-05 | 개시 | Guggenheim | Buy |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-10-07 | 개시 | BofA/Merrill | Buy |
| 2019-10-07 | 개시 | Cowen | Outperform |
| 2019-10-07 | 개시 | JP Morgan | Overweight |
| 2019-09-24 | 개시 | Evercore ISI | Outperform |
모두보기
10X 제노믹스 주식(TXG)의 최신 뉴스
10x Genomics Inc. Stock Analysis and ForecastPowerful growth strategies - Autocar Professional
What analysts say about 10x Genomics Inc. stockHigh-yield trading alerts - jammulinksnews.com
Is 10x Genomics Inc. a good long term investmentOutstanding investment returns - jammulinksnews.com
What drives 10x Genomics Inc. stock priceUnprecedented growth rates - jammulinksnews.com
10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study - Agency for Science, Technology and Research
Thermo Fisher, Exact Sciences, Integer Holdings, Revvity, and 10x Genomics Shares Are Falling, What You Need To Know - FinancialContent
10x Genomics Ends UPC Patent Fight With Bruker - Law360
10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery - the-scientist.com
Why 10x Genomics Inc. stock attracts strong analyst attentionFree Market Sentiment Analysis - beatles.ru
Acadia Healthcare, 10x Genomics, Amphastar Pharmaceuticals, Myriad Genetics, and QuidelOrtho Stocks Trade Down, What You Need To Know - Yahoo Finance
10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025 - BioSpace
Leading Spatial Biology Pioneer 10x Genomics Sets Q2 2025 Earnings Date: Key Details for Investors - Stock Titan
10x Genomics Reaches Analyst Target Price - Nasdaq
10x Genomics(TXG) Soars 7.88% on Strong Q1 Earnings - AInvest
10x Genomics Insiders Sold US$768k Of Shares Suggesting Hesitancy - 富途牛牛
10x Genomics, Inc.(NasdaqGS: TXG) dropped from Russell 1000 Value Index - MarketScreener
10x Genomics, Inc.(NasdaqGS: TXG) dropped from Russell Midcap Index - MarketScreener
10x Genomics (TXG) Receives a Hold from Bank of America Securities - The Globe and Mail
10x Genomics (TXG) Analyst Maintains Rating but Raises Price Target | TXG Stock News - GuruFocus
Life Sciences Tools & Services Stocks Q1 Results: Benchmarking 10x Genomics (NASDAQ:TXG) - Yahoo Finance
11 Best Genomics Stocks to Buy According to Hedge Funds - Insider Monkey
Revenues Not Telling The Story For 10x Genomics, Inc. (NASDAQ:TXG) After Shares Rise 31% - simplywall.st
10x Genomics Inc (TXG) Trading 4.12% Higher on Jun 18 - GuruFocus
UPC Backs Sales Ban On Kits Infringing 10x Genomics Patent - Law360
Delta, Macy's, CECO Environmental, RadNet, and 10x Genomics Shares Skyrocket, What You Need To Know - Yahoo Finance
Layoff Tracker: Gilead Cuts 36 Employees in California - BioSpace
Molecular Diagnostics for Cancer Market Research 2025: Advances in Personalized Medicine and Liquid Biopsies Reshape Industry Landscape - GlobeNewswire Inc.
Brown Capital Management Small Company Fund Sold 10x Genomics (TXG) Due to Fundamental Concerns - Insider Monkey
10x Genomics, Inc. (TXG) Stock Analysis: Evaluating A 28% Potential Upside For Investors - DirectorsTalk Interviews
Forecasting The Future: 7 Analyst Projections For 10x Genomics - Benzinga
Long Read Sequencing Market Key Players Analysis10X Genomics, - openPR.com
10x Genomics, Inc. (NASDAQ:TXG) Stock Holdings Increased by Deutsche Bank AG - Defense World
ARK Investment Acquires 290K Shares of 10x Genomics (TXG) | TXG Stock News - GuruFocus
10x Genomics, Inc. (TXG) Stock Analysis: Evaluating the 31.90% Potential Upside - DirectorsTalk Interviews
Cathie Wood's ARK Investment Acquires Significant Stake in 10x G - GuruFocus
10 Promising Biotech Stocks to Invest in (June 2025) - Securities.io
ARK Investment Acquires 342K Shares of 10x Genomics (TXG) | TXG Stock News - GuruFocus
Cetera Investment Advisers Raises Stake in 10x Genomics, Inc. (NASDAQ:TXG) - Defense World
Cathie Wood’s ARK buys Intellia, 10x Genomics, sells Tesla stock By Investing.com - Investing.com Nigeria
Cathie Wood’s ARK buys Intellia, 10x Genomics, sells Tesla stock - Investing.com India
10X 제노믹스 (TXG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
10X 제노믹스 주식 (TXG) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Hindson Benjamin J. | See Remarks |
May 22 '25 |
Sale |
8.30 |
7,485 |
62,120 |
448,374 |
| Taich Adam | Chief Financial Officer |
May 22 '25 |
Sale |
8.30 |
4,044 |
33,562 |
331,588 |
0.40%
0.10%
자본화:
|
볼륨(24시간):